Background and Aims: Atrial fibrillation (AF) occurs frequently in patients with chronic obstructive pulmonary disease (COPD). There are limited data about the impact of AF in hospitalized COPD patients on other serious health outcomes, such as acute organ dysfunction, severe sepsis and respiratory failure. The aim of our study was to delineate the impact of AF in hospitalized COPD patients.
Results: The primary outcome probability was higher in COPD patients with AF than in COPD patients without AF, with an adjusted hazard ratio (aHR) of 1.170 (95% confidence interval (CI): 1.030-1.329), and higher risks of acute organ dysfunction and respiratory failure were also observed in the former group, with aHRs of 1.179 (95% CI: 1.0370-1.339) and 1.176 (95% CI: 1.006-1.374), respectively.
Conclusion:
Compared with COPD patients without AF, COPD patients with AF had a higher risk of hepatic dysfunction and respiratory failure. Hallym university Kangnam Sacred Heart Hospital, South Korea Background and Aims: Although non-invasive positive pressure ventilation (NIPPV) treatment for acute respiratory failure improves the outcome in COPD patients the results of studies in which COPD chronic respiratory distress was treated with NIPPV vary widely. We aimed to evaluate the long-term effect of domiciliary NIPPV.
Methods:
We performed an extensive search of the MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases to identify randomized controlled trials (RCTs) pertaining to the long-term treatment of COPD with NIPPV ventilation over a period of more than 1 year.
Results:
The eight trials included in this study comprised data from 913 patients. The mortality rates for the NIPPV and control groups, were 29% (118/414) and 36% (151/419). This difference was statistically significant (RR, 0.79; 95% CI, 0.65-0.95, P = 0.01). The mortality rates in the four trials that included stable COPD patients were reduced on application of NIPPV (RR 0.71, 95% CI 0.56-0.91, P = 0.006). In a further subgroup analysis, mortality was reduced when the mean baseline PaCO2 level was high (RR 0.71, 95% CI 0.55-0.93, P = 0.01). The results of the subgroup analysis according to the mean IPAP level showed that the mortality rates in the NIPPV group in three trials were reduced (RR 0.72, 95% CI 0.54-0.96, P = 0.03). There was no difference in QOL between NIPPV and control groups (SMD −0.037, 95% CI −0.34-0.29, P = 0.85). There was no significant difference in the dropout rate between the two groups. (RR 0.99, 95% CI 0.72-1.36,
Conclusion: Domiciliary NIPPV should be considered in COPD patients especially when used in patients with a stable status and relatively higher PaCO2 level, and among those with a higher IPAP level. can detect impairments of lung function by measuring the impedance of respiratory system (Zrs; respiratory resistance (Rrs) and respiratory reactance (Xrs)) during normal tidal breathing. Because the representative value of Zrs measured by FOT is the average value of total breathing/ expiration/ inspiration period, there is little consideration on the dynamic change in Zrs during the respiratory cycle.
We assessed the change in Zrs during early expiratory phase.
Methods: 19 male subjects underwent the normal spirometry test (CHESTAC 55-V, CHEST MI. Inc., Tokyo, Japan) and Zrs measurement (MostGraph-01, Ver.1.70R, CHEST MI. Inc., Tokyo, Japan) on the same day. We divided subjects into two groups by the result of the spirometry test; normal group (n = 4, mean age 55 years) and COPD group (n = 15, mean age 66 years). Furthermore we made three subgroups in COPD group; mild COPD (≧80% of %FEV1.0, n = 6), moderate COPD (50-80% of %FEV1.0, n = 5) and sever COPD (<50% of %FEV1.0, n = 4).
We analyzed Zrs at the time of expiration started (Zrs(es)) and 0.5 second after the start of expiration (Zrs(0.5)).
Results: There was no constant trend in Zrs during total breathing, exhalation, and inspiration period within all groups. Rrs of 5 Hz (R5) at 0.5 s (R5(0.5)) increased 2.70, 2.82, 3.74, 3.95 cmH 2 O/L/s (normal, mild, moderate, severe group, respectively). Xrs of 5 Hz (X5) at 0.5 (X5(0.5)) was decreased 1.25, 1.14, 0.89, 0.53 cmH2O/L/sec (normal, mild, moderate, severe group, respectively). ΔR5-20, the difference of R5-20 between R5-20(0.5) and R5-20(es), was increased along with severity of COPD; 0.29, 0.47, 0.50, 0.88 cm H 2 O/L/s (normal, mild, moderate, severe group, respectively). V25 showed a negative correlation tendency with R5(0.5) and ΔR5-20.
Conclusion:
It was suggested that Zrs in the early phase of resting expiration was related with the severity of COPD. Changhua Christian Hospital /pharmacy, Taiwan Background and Aims: Chronic obstructive pulmonary disease, COPD is characterized by an abnormal inflammatory response in the lungs and restricted airflow, which both result in difficulty doing the most vital thing in life -breathing. We would like to know whether the use of probiotics can improve the inflammation or the relief of symptoms in patients with COPD.
Methods: We performed a systematic literature search in PubMed, Embase, and Cochrane Library in any language from inception to May 2018 by using the key words-(copd [MeSH] OR Asthma[MeSH] ) AND ("probiotic agent" OR probiotic#) NOT (atopic OR allerg*). We included 2 RCTs and 1 review to appraisal by casp tool. 
